Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Kahal H, Kyrou I, Uthman OA, Brown A, Johnson S, Wall PDH, Metcalfe A, Parr DG, Tahrani AA, Randeva HS.

Sleep Breath. 2019 May 20. doi: 10.1007/s11325-019-01835-1. [Epub ahead of print] Review.

PMID:
31111411
2.

Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.

Stoel BC, Stolk J, Bakker ME, Parr DG.

Respir Res. 2019 Feb 28;20(1):45. doi: 10.1186/s12931-019-1012-3.

3.

European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.

Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, McElvaney NG, Parr D, Piitulainen E, Roche N, Stolk J, Thabut G, Turner A, Vogelmeier C, Stockley RA.

Eur Respir J. 2017 Nov 30;50(5). pii: 1700610. doi: 10.1183/13993003.00610-2017. Print 2017 Nov. Review.

4.

Influence of exercise duration on cardiorespiratory responses, energy cost and tissue oxygenation within a 6 hour treadmill run.

Kerhervé HA, McLean S, Birkenhead K, Parr D, Solomon C.

PeerJ. 2017 Oct 9;5:e3694. doi: 10.7717/peerj.3694. eCollection 2017.

5.

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.

Parr DG, Lara B.

Drug Des Devel Ther. 2017 Jul 14;11:2149-2162. doi: 10.2147/DDDT.S105207. eCollection 2017. Review.

6.

Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.

Engel M, Endesfelder D, Schloter-Hai B, Kublik S, Granitsiotis MS, Boschetto P, Stendardo M, Barta I, Dome B, Deleuze JF, Boland A, Müller-Quernheim J, Prasse A, Welte T, Hohlfeld J, Subramanian D, Parr D, Gut IG, Greulich T, Koczulla AR, Nowinski A, Gorecka D, Singh D, Gupta S, Brightling CE, Hoffmann H, Frankenberger M, Hofer TP, Burggraf D, Heiss-Neumann M, Ziegler-Heitbrock L, Schloter M, Zu Castell W.

PLoS One. 2017 Jul 13;12(7):e0180859. doi: 10.1371/journal.pone.0180859. eCollection 2017.

7.

Quantifying the Lung at Risk in Chronic Obstructive Pulmonary Disease. Does Emphysema Beget Emphysema?

Parr DG.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):535-536. doi: 10.1164/rccm.201705-0962ED. No abstract available.

PMID:
28609633
8.

Quantification of Lung PET Images: Challenges and Opportunities.

Chen DL, Cheriyan J, Chilvers ER, Choudhury G, Coello C, Connell M, Fisk M, Groves AM, Gunn RN, Holman BF, Hutton BF, Lee S, MacNee W, Mohan D, Parr D, Subramanian D, Tal-Singer R, Thielemans K, van Beek EJ, Vass L, Wellen JW, Wilkinson I, Wilson FJ.

J Nucl Med. 2017 Feb;58(2):201-207. doi: 10.2967/jnumed.116.184796. Epub 2017 Jan 12. Review.

9.

Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.

Subramanian DR, Gupta S, Burggraf D, Vom Silberberg SJ, Heimbeck I, Heiss-Neumann MS, Haeussinger K, Newby C, Hargadon B, Raj V, Singh D, Kolsum U, Hofer TP, Al-Shair K, Luetzen N, Prasse A, Müller-Quernheim J, Benea G, Leprotti S, Boschetto P, Gorecka D, Nowinski A, Oniszh K, Castell WZ, Hagen M, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Koczulla AR, Gut I, Hohlfeld J, Welte T, Lavae-Mokhtari M, Ziegler-Heitbrock L, Brightling C, Parr DG.

Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.

10.

Lung density associates with survival in alpha 1 antitrypsin deficient patients.

Green CE, Parr DG, Edgar RG, Stockley RA, Turner AM.

Respir Med. 2016 Mar;112:81-7. doi: 10.1016/j.rmed.2016.01.007. Epub 2016 Jan 22.

11.

Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.

Levenick JM, Gordon SR, Fadden LL, Levy LC, Rockacy MJ, Hyder SM, Lacy BE, Bensen SP, Parr DD, Gardner TB.

Gastroenterology. 2016 Apr;150(4):911-7; quiz e19. doi: 10.1053/j.gastro.2015.12.040. Epub 2016 Jan 9.

12.

Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography.

Gupta S, Hartley R, Singapuri A, Hargadon B, Monteiro W, Pavord ID, Sousa AR, Marshall RP, Subramanian D, Parr D, Entwisle JJ, Siddiqui S, Raj V, Brightling CE.

Am J Respir Crit Care Med. 2015 Jan 1;191(1):107-10. doi: 10.1164/rccm.201406-1128LE. No abstract available.

13.

Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients.

Gupta S, Hartley R, Khan UT, Singapuri A, Hargadon B, Monteiro W, Pavord ID, Sousa AR, Marshall RP, Subramanian D, Parr D, Entwisle JJ, Siddiqui S, Raj V, Brightling CE.

J Allergy Clin Immunol. 2014 Mar;133(3):729-38.e18. doi: 10.1016/j.jaci.2013.09.039. Epub 2013 Nov 12.

14.

Prevalence and radiological outcomes of lung nodules in alpha 1-antitrypsin deficiency.

Subramanian DR, Edgar R, Ward H, Parr DG, Stockley RA.

Respir Med. 2013 Jun;107(6):863-9. doi: 10.1016/j.rmed.2012.12.021. Epub 2013 Jan 20.

15.

Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.

Subramanian DR, Jenkins L, Edgar R, Quraishi N, Stockley RA, Parr DG.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1125-32. doi: 10.1164/rccm.201201-0051OC. Epub 2012 Jul 26.

PMID:
22837375
16.

The EvA study: aims and strategy.

Ziegler-Heitbrock L, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Häussinger K, Brightling C, Gupta S, Parr D, Subramanian D, Singh D, Kolsum U, Boschetto P, Potena A, Gorecka D, Nowinski A, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Bals R, Hohlfeld JM, Welte T, Venge P, Gut I, Boland A, Olaso R, Hager J, Hiemstra P, Rabe KF, Unmüssig M, Müller-Quernheim J, Prasse A.

Eur Respir J. 2012 Oct;40(4):823-9. Epub 2012 Mar 22.

17.

Patient phenotyping and early disease detection in chronic obstructive pulmonary disease.

Parr DG.

Proc Am Thorac Soc. 2011 Aug;8(4):338-49. doi: 10.1513/pats.201101-014RM. Review.

PMID:
21816990
18.

Eureka?

Stoel BC, Dirksen A, Stockley RA, Parr D, Piitulainen E, Shaker SB, Russi EW, Bakker ME, Reiber JH, Stolk J.

Radiology. 2011 May;259(2):610-1; author reply 611-2. doi: 10.1148/radiol.11102262. No abstract available.

PMID:
21502395
19.
20.

Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiency.

Holme J, Dawkins PA, Stockley EK, Parr DG, Stockley RA.

COPD. 2010 Apr;7(2):126-32. doi: 10.3109/15412551003631733.

PMID:
20397813
21.

Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.

Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA.

Respir Res. 2009 Aug 13;10:75. doi: 10.1186/1465-9921-10-75.

22.

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA.

Eur Respir J. 2009 Jun;33(6):1345-53. doi: 10.1183/09031936.00159408. Epub 2009 Feb 5.

23.

Volume correction in computed tomography densitometry for follow-up studies on pulmonary emphysema.

Stoel BC, Putter H, Bakker ME, Dirksen A, Stockley RA, Piitulainen E, Russi EW, Parr D, Shaker SB, Reiber JH, Stolk J.

Proc Am Thorac Soc. 2008 Dec 15;5(9):919-24. doi: 10.1513/pats.200804-040QC.

PMID:
19056717
24.

nan'o.tech.nol'o.gy n.

Theis T, Parr D, Binks P, Ying J, Drexler KE, Schepers E, Mullis K, Bai C, Boland JJ, Langer R, Dobson P, Rao CN, Ferrari M.

Nat Nanotechnol. 2006 Oct;1(1):8-10. doi: 10.1038/nnano.2006.77. No abstract available.

PMID:
18654128
25.

Can the extent of low-attenuation areas on CT scans really demonstrate changes in the severity of emphysema?

Stoel BC, Parr DG, Bakker EM, Putter H, Stolk J, Gietema HA, Schilham AM, van Ginneken B, van Klaveren RJ, Lammers JW, Prokop M.

Radiology. 2008 Apr;247(1):293-4; author reply 294. doi: 10.1148/radiol.2471071608. No abstract available.

PMID:
18372475
26.

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.

Parr DG, Sevenoaks M, Deng C, Stoel BC, Stockley RA.

Respir Res. 2008 Feb 13;9:21. doi: 10.1186/1465-9921-9-21.

27.

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF; American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD.

Eur Respir J. 2008 Feb;31(2):416-69. doi: 10.1183/09031936.00099306. Review.

28.

Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.

Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA.

Am J Respir Crit Care Med. 2007 Dec 15;176(12):1215-21. Epub 2007 Sep 13.

PMID:
17872489
29.

Progression parameters for emphysema: a clinical investigation.

Stolk J, Putter H, Bakker EM, Shaker SB, Parr DG, Piitulainen E, Russi EW, Grebski E, Dirksen A, Stockley RA, Reiber JH, Stoel BC.

Respir Med. 2007 Sep;101(9):1924-30. Epub 2007 Jul 20.

30.
31.
33.

Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study.

Parr DG, White AJ, Bayley DL, Guest PJ, Stockley RA.

Respir Res. 2006 Nov 18;7:136.

34.

Computed tomography: a new gold standard for the clinical assessment of emphysema.

Parr DG, Dawkins PA, Stockley RA.

Am J Respir Crit Care Med. 2006 Oct 15;174(8):954; author reply 954-5. No abstract available.

PMID:
17021361
35.

Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.

Parr DG, Stoel BC, Stolk J, Stockley RA.

Thorax. 2006 Jun;61(6):485-90. Epub 2006 Mar 14.

36.

Variability in densitometric assessment of pulmonary emphysema with computed tomography.

Bakker ME, Stolk J, Putter H, Shaker SB, Parr DG, Piitulainen E, Russi EW, Dirksen A, Stockley RA, Reiber JH, Stoel BC.

Invest Radiol. 2005 Dec;40(12):777-83.

PMID:
16304481
37.

Unlike climate science, GM is full of uncertainties.

Parr D.

Nature. 2005 Jul 21;436(7049):328. No abstract available.

PMID:
16034396
38.

Will nanotechnology make the world a better place?

Parr D.

Trends Biotechnol. 2005 Aug;23(8):395-8.

PMID:
15967522
39.

Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment.

Parr DG, Stoel BC, Stolk J, Stockley RA.

Am J Respir Crit Care Med. 2004 Dec 1;170(11):1172-8. Epub 2004 Aug 11.

PMID:
15306534
40.

Influence of calibration on densitometric studies of emphysema progression using computed tomography.

Parr DG, Stoel BC, Stolk J, Nightingale PG, Stockley RA.

Am J Respir Crit Care Med. 2004 Oct 15;170(8):883-90. Epub 2004 Jul 21.

PMID:
15271692
41.

Standardization of CT densitometry.

Parr DG, Stockley RA.

Radiology. 2004 Mar;230(3):887; author reply 887. No abstract available.

PMID:
14990850
42.

Nanoscience debate.

Parr D.

Lancet. 2003 Oct 18;362(9392):1332-3. No abstract available.

PMID:
14575995
43.

Panniculitis secondary to extravasation of clarithromycin in a patient with alpha 1-antitrypsin deficiency (phenotype PiZ).

Parr DG, Stewart DG, Hero I, Stockley RA.

Br J Dermatol. 2003 Aug;149(2):410-3.

PMID:
12932253
44.

Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin.

Lim AY, Parr DG, Stableforth DE, Fellows M, Fontaine R, Fegan CD.

Eur J Intern Med. 2003 Mar;14(2):89-93.

PMID:
12719024
45.

A retained surgical swab.

Hucker T, Schaeffer B, Wakeling H, Parr D.

Anaesthesia. 2001 Nov;56(11):1126-7. No abstract available.

46.

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, Marriott D, Pfeiffer T, Parr D, Byth K.

Clin Infect Dis. 2000 Aug;31(2):499-508. Epub 2000 Sep 7.

PMID:
10987712
47.

Evidence for a general-purpose genotype in Candida albicans, highly prevalent in multiple geographical regions, patient types and types of infection.

Schmid J, Herd S, Hunter PR, Cannon RD, Yasin MS, Samad S, Carr M, Parr D, McKinney W, Schousboe M, Harris B, Ikram R, Harris M, Restrepo A, Hoyos G, Singh KP.

Microbiology. 1999 Sep;145 ( Pt 9):2405-13.

PMID:
10517593
48.
49.

Maxillary sinusitis caused by medusoid form of Schizophyllum commune.

Sigler L, Bartley JR, Parr DH, Morris AJ.

J Clin Microbiol. 1999 Oct;37(10):3395-8.

50.

How to restore public trust in science.

Haerlin B, Parr D.

Nature. 1999 Aug 5;400(6744):499. No abstract available.

PMID:
10448847

Supplemental Content

Support Center